In the last trading session, 13,128,212 Ocugen, Inc. (NASDAQ:OCGN) shares changed hands as the company’s beta touched 4.41. With the company’s per share price at $6.5 changed hands at -$0.63 or -0.09% during last session, the market valuation stood at $1.22 Billion. OCGN’s last price was a discount, traded about -188.77% off its 52-week high of $18.77. The share price had its 52-week low at $0.17, which suggests the last value was 97.38% up since then. When we look at Ocugen, Inc.’s average trading volume, we note the 10-day average is 14.76 Million shares, with the 3-month average coming to 62.83 Million.
Analysts gave the Ocugen, Inc. (OCGN) stock a consensus recommendation rating of Overweight, calculated at a mean rating of 2.2. If we narrow down to specifics, the data shows that none out of 4 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, 1 recommended OCGN as a Hold, 3 felt it is a Buy and none rated the stock as Underweight. Ocugen, Inc.’s EPS for the current quarter is expected to be $0.49.
Ocugen, Inc. (NASDAQ:OCGN) trade information
Although OCGN has turned red as seen at the end of in last trading. With action -8.84%, the performance over the past five days has been red. The jump to weekly highs of $8.58- on Tuesday, Mar 23 added 24.24% to the stock’s daily price. The company’s shares are showing year-to-date upside of 2.55%, with the 5-day performance at -0.24% in the red. However, in the 30-day time frame, Ocugen, Inc. (NASDAQ:OCGN) is -0.41% down. Looking at the short shares, we see there were 13.02 Million shares sold at short interest cover period of 0.21 days.
The consensus price target for the stock as assigned by Wall Street analysts is $12.5, meaning bulls need an upside of 92.31% from its current market value. According to analyst projections, OCGN’s forecast low is $10 with $15 as the target high. To hit the forecast high, the stock’s price needs a +130.77% upsurge from its current level, while the stock would need to tank 53.85% for it to hit the projected low.
Ocugen, Inc. (OCGN) estimates and forecasts
Data shows that the Ocugen, Inc. share is not performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot +2041.68% over the past 6 months, a -667.74% in annual growth rate that is considerably lower than the industry average of 7%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2021 revenue estimates. The rating firms predict current quarter revenue for Ocugen, Inc. will rise +800%, while the growth in revenue is estimated to hit 294.7% for the next quarter. Year-over-year growth is forecast to reach 1051807% up from the last financial year.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 70.8%. The 2021 estimates are for Ocugen, Inc. earnings to increase by 79%, but the outlook for the next 5-year period is at 0% per year.
Ocugen, Inc. (NASDAQ:OCGN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.26% of Ocugen, Inc. shares while 13.12% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 13.57%. There are 19 institutions holding the Ocugen, Inc. stock share, with Vanguard Group, Inc. (The) the top institutional holder. As of Dec 30, 2020, the company held 4.82% of the shares, roughly 9.07 Million OCGN shares worth $16.61 Million.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Blackrock Inc. holds the second largest percentage of outstanding shares, with 1.18% or 2.23 Million shares worth $4.07 Million as of Dec 30, 2020.
Among Mutual Funds, the top two as of Dec 30, 2020 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 6637849 shares estimated at $12.15 Million under it, the former controlled 3.53% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.17% of the shares, roughly 2.2 Million shares worth around $4.03 Million.